Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: Nov 12, 2025
Topline data from registrational trial in stiff person syndrome (SPS) now expected in early 2026; narrowed from previous guidance of first half 2026; BLA submission anticipated in 1H 2026
Read more at globenewswire.com
